Results 131 to 140 of about 10,894,164 (293)

The pursuit of noble prize in physiology and medicine: Current challenges in Indian research environment-A new frame of reference. [PDF]

J Family Med Prim Care, 2023
Dhanlika D, Bhadoria AS.
europepmc   +1 more source

Colorectal cancer‐derived FGF19 is a metabolically active serum biomarker that exerts enteroendocrine effects on mouse liver

Molecular Oncology, EarlyView.
Meta‐transcriptome analysis identified FGF19 as a peptide enteroendocrine hormone associated with colorectal cancer prognosis. In vivo xenograft models showed release of FGF19 into the blood at levels that correlated with tumor volumes. Tumoral‐FGF19 altered murine liver metabolism through FGFR4, thereby reducing bile acid synthesis and increasing ...
Jordan M. Beardsley, Michael W. Rohr, Joseph A. Goode, Sai Preethi Nakkina, Jignesh G. Parikh, Deborah A. Altomare   +5 more
wiley   +1 more source

Digital Research Environment(DRE)-enabled Artificial Intelligence (AI) to facilitate early stage drug development. [PDF]

Front Pharmacol, 2023
Barrett JS, Oskoui SE, Russell S, Borens A.   +3 more
europepmc   +1 more source

Integrated design optimization research and development in an industrial environment [PDF]

An overview is given of a design optimization project that is in progress at the GE Research and Development Center for the past few years. The objective of this project is to develop a methodology and a software system for design automation and ...
German, Marjorie D., Kumar, V., Lee, S.-J.   +2 more
core   +1 more source

Genetic attenuation of ALDH1A1 increases metastatic potential and aggressiveness in colorectal cancer

Molecular Oncology, EarlyView.
Aldehyde dehydrogenase 1A1 (ALDH1A1) is a cancer stem cell marker in several malignancies. We established a novel epithelial cell line from rectal adenocarcinoma with unique overexpression of this enzyme. Genetic attenuation of ALDH1A1 led to increased invasive capacity and metastatic potential, the inhibition of proliferation activity, and ultimately ...
Martina Poturnajova, Zuzana Kozovska, Ondrej Pos, Kristina Pavlov, Sachin Gulati, Peter Makovicky, Kristina Jakic, Monika Burikova, Eva Sedlackova, Barbora Svitkova, Silvia Tyciakova, Vojtech Bystry, Nicolas Blavet, Boris Tichy, Matej Hrnciar, Jaroslav Budis, Miroslav Tomas, Peter Dubovan, Georgina Kolnikova, Veronika Repaska, Nikoleta Mojzesova, Eva Zomborska, Daniel Pindak, Michal Mego, Tomas Szemes, Miroslava Matuskova   +25 more
wiley   +1 more source

The health informatics centre: a safe haven and trusted research environment enabling world-leading research. [PDF]

Int J Popul Data Sci, 2023
Ward LM, Johnston J, Milburn KR, Hall C, Jones C, Guignard-Duff M, Krueger S, Milligan G, Anderson J, Walls R, Cole C.   +10 more
europepmc   +1 more source

Dimethyl fumarate combined with cisplatin at subcytotoxic doses sensitizes cervical cancer toward ferroptosis and apoptosis through GSH restriction and p53 (re)activation

Molecular Oncology, EarlyView.
Dimethyl fumarate (DMF) reduces growth of HPV‐positive cervical cancer spheroids and induces ferroptosis in cervical cancer cells via blocking SLC7A11/Glutathione (GSH) axis. Combination of subcytotoxic doses of DMF and cisplatin (CDDP) further suppresses spheroid growth and drives cell death in 2D culture models.
Carolina Punziano, Giuseppina Minopoli, Simona Romano, Laura Marrone, Katia Aquilano, Maria Lina Tornesello, Raffaella Faraonio   +6 more
wiley   +1 more source

The research environment of critical care in three Asian countries: A cross-sectional questionnaire survey. [PDF]

Front Med (Lausanne), 2022
Kotani Y, Na S, Phua J, Shime N, Kawasaki T, Yasuda H, Jun JH, Kawaguchi A.   +7 more
europepmc   +1 more source

Targeted modulation of IGFL2‐AS1 reveals its translational potential in cervical adenocarcinoma

Molecular Oncology, EarlyView.
Cervical adenocarcinoma patients face worse outcomes than squamous cell carcinoma counterparts despite similar treatment. The identification of IGFL2‐AS1's differential expression provides a molecular basis for distinguishing these histotypes, paving the way for personalized therapies and improved survival in vulnerable populations globally.
Ricardo Cesar Cintra, Lucca Paolo Hsu Helmich, Daniel Rodrigues de Bastos, Laura Sichero, Patrícia Savio de Araujo‐Souza, Fabio Passetti, Luisa Lina Villa   +6 more
wiley   +1 more source

Creating a collaborative and impactful research environment: community partner reflections on the DeStress-II study. [PDF]

Res Involv Engagem
Horrell J, McLoughlin A, Thomas F, Berzins K, Hughes S, Guppy K, Perkins P, Corkhill R, Sherlock D, Ahmed S, Gul S, Holt K, Coombes K, Yameen F, Hamer O, Wyatt K.   +15 more
europepmc   +2 more sources